Analyst Price Targets — BLFS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 5, 2026 2:17 pm | — | Northland Securities | $34.00 | $25.14 | TheFly | BioLife Solutions price target raised, named a 2026 Top Pick at Northland |
| November 24, 2025 11:40 am | Yi Chen | H.C. Wainwright | $32.00 | $26.53 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on BioLife Solutions (BLFS) |
| March 5, 2025 5:11 pm | — | H.C. Wainwright | $30.00 | $26.25 | TheFly | BioLife Solutions price target raised to $30 from $27 at H.C. Wainwright |
| November 15, 2024 12:14 pm | Jacob Johnson | Stephens | $30.00 | $21.58 | StreetInsider | Stephens Reiterates Overweight Rating on BioLife Solutions (BLFS) |
| August 12, 2024 8:39 am | Matt Hewitt | Craig-Hallum | $30.00 | $25.25 | TheFly | BioLife Solutions price target raised to $30 from $23 at Craig-Hallum |
| April 4, 2024 2:41 am | Matthew Stanton | Jefferies | $22.00 | $17.32 | StreetInsider | Jefferies Starts BioLife Solutions (BLFS) at Buy, 'Getting Back to Basics, Cleaner Story Post Pending Freezer Divestiture' |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for BLFS

On May 28, 2026, BioLife Solutions Inc (BLFS) shares rose 3.1% to a current price of $25.25. This movement comes amid a 52-week range that sees a high of $29.62

BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript

BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.04 per share a year ago.

Total revenue of $27.5 million, up 25% over Q1 2025 GAAP gross margin and non-GAAP adjusted gross margin of 64% GAAP net income of $1.2 million and non-GAAP adjusted EBITDA of $6.2 million or 22% of revenue Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash.

The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. PAHC, BLFS, OMER and BWAY reflect the favorable fundamentals.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BLFS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
